Evaluation And Prediction Of Treatment Response In Liver Metastasis Undergoing Chemotherapy With Use Of Dual Energy CT Iodine Quantification Technique
Brief description of study
If you have been diagnosed with spread of your cancer to the liver, you may qualify for a clinical trial to develop and validate a new Dual Energy CT (DECT) Iodine Quantification Technique to evaluate and predict how well your tumors shrink after undergoing chemotherapy. The goal of the study is to develop and validate DECT technique in order to evaluate and predict how well tumors shrink in patients undergoing therapy for liver metastasis or liver cancer.
Clinical Study Identifier: 10-00841
ClinicalTrials.gov Identifier: NCT10-00841
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
